Fidaxomicin

Restricted
C difficile risk
None
Oral Bioavailability
None

Spectrum Of Activity

Dosing

C. difficile 200mg po BID x 10days

General Information

C. difficile colitis

  • GI disturbance

  • Cytopenias

  • Hypersensitivity: facial, tongue or throat swelling

Consult Infectious Disease

Antimicrobial class: Specialized anti-C. difficile macrocyclic agent

Pregnancy category: B

Urine penetration: None

Lung penetration: None

CSF penetration: None

Biliary penetration: None